Crossmark

Immunometabolic reprogramming in multiple sclerosis: from pathogenic amplifier to therapeutic target in neuroinflammation and remyelination

Published Online: 2026-07-28

Authors

Badawi, Ghada A.

El-Sayed, Rehab M.

Fawzy, Mohamed N. https://orcid.org/0000-0002-3025-2343
Funding

Funding for this research was provided by:

Sinai University
License Information

Text and Data Mining valid from 2026-07-28

Version of Record valid from 2026-07-28
More Information

Article History

Received: 13 May 2026

Accepted: 14 July 2026

First Online: 28 July 2026

Declarations

Conflict of interest: The authors declare no conflict of interest.

Document is current